RecruitingNCT06465277

CMR Right Ventricular Contractile Reserve Following Lung Resection

Assessment of Right Ventricular Contractile Reserve Following Lung Resection by Dobutamine Stress Cardiac Magnetic Resonance: a Feasibility Study


Sponsor

Belfast Health and Social Care Trust

Enrollment

42 participants

Start Date

Jul 21, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

Feasibility study investigating CMR dobutamine stress testing before and after lung resection


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is using cardiac MRI to measure how well the right side of the heart adapts to the stress of lung or major abdominal surgery. It aims to predict which patients may develop heart or breathing complications after surgery. **You may be eligible if...** - You are over 16 years old - You are scheduled for an elective lobectomy (lung removal), esophagectomy, or gastrectomy surgery **You may NOT be eligible if...** - You are pregnant - You have atrial fibrillation - You have a pacemaker, metal implants, cochlear implant, or other MRI contraindications - You are currently enrolled in another research study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTDobutamine stress CMR

Dobutamine stress testing will be undertaken in keeping with local departmental clinical guidelines with a graded increase in dobutamine infusion up to a maximum of 10microgram/kg/min. The patients' medications will be managed in keeping with the usual clinical practice and departmental guidelines. At rest and on each graded level of dobutamine infusion we will collect cine loops of the cardiac cycle including a short-axis stack of the ventricles, a four-chamber view and flow imaging perpendicular to the main, left and right pulmonary arteries. Post-processing will be dual reported by blinded observers using the Argus analysis software (Siemens) according to a standardised protocol. A safety report of each CMR scan will be generated by a consultant cardiologist, any abnormalities identified will be referred to the appropriate medical speciality and highlighted to the patient's clinical team.

DIAGNOSTIC_TESTCardiac biomarker sample

blood samples will be collected pre-operatively, in recovery, on post-operative days 1 and 2, and at 4-8 weeks post-operatively


Locations(1)

Belfast Health and Social Care Trust

Belfast, Northern Ireland, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06465277


Related Trials